Macular Degeneration Gene Link Raises Concerns Over RNAi-Based Therapies | GenomeWeb
NEW YORK (GenomeWeb News) – New research is providing insights into the genetics behind one form of macular degeneration — and raising red flags about the indiscriminate use of RNAi-based therapies for treating other forms of the disease.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.